Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

UK Research and Innovation provides additional funds for whole genome sequencing as part of the OxPLoreD programme of research into high-risk conditions for blood cancer.

Similar stories

New clinical prediction tools for myeloma

Myeloma

Dr Constantinos Koshiaris has developed clinical prediction models for use in primary care with the aim of accelerating myeloma diagnoses.

7 year collaboration with Janssen to detect blood cancers earlier

Myeloma

A new 7-year study in collaboration with Janssen Research & Development aims to enable earlier detection of blood cancers.